Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Wonderlab Kids instant probiotics
Chongqing Precision Biotech Co., Ltd
Immunity
1 trial -
Wonderlab Nicotinamide Drink
Chongqing Precision Biotech Co., Ltd
Skin Darken
1 trial -
Yin and Yang tonic granules
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Osteopenia
1 trial -
Zinc gluconate
Grace Therapeutics
HIV
1 trial -
active tDCS and cognitive training intervention
United Therapeutics Europe Ltd
Brain Concussion
2 trials -
alteplase or tenecteplase
United Therapeutics Europe Ltd
CVA (Cerebrovascular Accident)
1 trial -
amorphous calcium carbonate/ Placebo
Universal Integrated
Calcium
1 trial -
anti-thymocyte globulin
Ultragenyx UK Limited
Immunologic Deficiency Syndromes
1 trial -
anti-thymocyte globulin
Ultragenyx UK Limited
Neutropenia
1 trial -
anti-thymocyte globulin
Ultragenyx UK Limited
Graft Versus Host Disease
1 trial -
anti-thymocyte globulin
Ultragenyx UK Limited
Chediak-Higashi Syndrome
1 trial -
anti-thymocyte globulin
Ultragenyx UK Limited
Purpura, Schoenlein-Henoch
1 trial -
anti-thymocyte globulin
United Therapeutics Europe Ltd
Leukemia
1 trial -
antihistamine(low dose) chlorpheniramine (Dexchlorpheniramine maleate)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Pain
1 trial -
atosiban
Hospital Authority, Hong Kong
Repeated Implantation Failure
1 trial -
bicycle ergometry test with spiroergometry
The First People's Hospital of Lianyungang
Community-acquired Pneumonia
1 trial -
bismuth-containing quadral therapy based on antibiotic susceptibility
Shandong University
Helicobacter Pylori
1 trial -
bitter melon peptides
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Diabetes
1 trial -
botulinum toxin type A
Ultragenyx UK Limited
Hyperhidrosis
1 trial -
bpMRI
United Therapeutics Europe Ltd
Prostate Cancer
1 trial -
brachytherapy
United Therapeutics Europe Ltd
Prostate Cancer
1 trial -
caFFR
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Coronary Artery Disease
1 trial -
calcitriol
Ultragenyx UK Limited
Psoriasis
1 trial -
carbohydrates
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Insulin Resistance
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources